Benzathine penicillin G stockouts and other barriers to documented syphilis treatment in pregnancy in Zambia.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 05 12 2023
accepted: 15 05 2024
medline: 3 6 2024
pubmed: 3 6 2024
entrez: 3 6 2024
Statut: epublish

Résumé

The prevalence of syphilis in Zambia remains high and is a critical public health concern. The Zambian Ministry of Health recommends universal screening and same-day treatment for syphilis in pregnancy, yet the syphilis screening rate is low, and treatment is poorly documented. The goal of this study was to document syphilis treatment rates and associated factors among pregnant women in care in Zambia. This retrospective cohort study included pregnant women diagnosed with syphilis according to rapid plasma reagin (RPR) screening during routine antenatal care (ANC) in Lusaka, Zambia in 2018-2019. The main outcome of interest was lack of documented BPG treatment during pregnancy. Additional information about pregnancy and neonatal outcomes, partner referral for therapy, and facility level stockout data were included. Patient characteristics were compared by treatment status using Pearson Chi-Square Test and logistic regression models were created to estimate the association between individual level-factors, facility type, and lack of BPG treatment. A Cochran-Mantel-Haenszel test was used to evaluate facility-level data with significance set at p<0.05. Among 1,231 pregnant women who screened positive for syphilis at clinic, 643 (52%) lacked documented antibiotic treatment at the facility. BPG was the only antibiotic used to treat syphilis in the cohort and 8% of sex partners had evidence of referral for therapy. Preterm delivery rates were higher in women without documented BPG (43% vs 32%; p = 0.003). In adjusted models, only calendar year and hospital facility type were associated with lack of treatment. At the facility level, annual syphilis screening rates ranged from 37-65% and most (7/10) clinics reported at least one stockout of BPG. Treatment rates for syphilis in pregnancy in Zambia were low and BPG medication stockouts at the facility level were common. A consistent supply of BPG at all ANC facilities is needed to facilitate timely treatment and improve birth outcomes.

Identifiants

pubmed: 38829879
doi: 10.1371/journal.pone.0304576
pii: PONE-D-23-37341
doi:

Substances chimiques

Penicillin G Benzathine RIT82F58GK
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0304576

Informations de copyright

Copyright: © 2024 Jones et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Anna V Jones (AV)

Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.

Albert Manasyan (A)

Department of Pediatrics, University of Alabama at Birmingham, Children's of Alabama Hospital, Birmingham, Alabama, United States of America.
Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Yumo Xue (Y)

Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.

Herbert Kapesa (H)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Kate Mwendafilumba (K)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Leukanji Nalwamba (L)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Maureen Mzumara (M)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Mwangelwa Mubiana-Mbewe (M)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Jodie A Dionne (JA)

Center for Women's Reproductive Health, University of Alabama at Birmingham, University of Alabama at Birmingham Hospital, Birmingham, Alabama, United States of America.
Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, University of Alabama at Birmingham Hospital, Birmingham, Alabama, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH